The invention discloses a pharmaceutical composition for treating
lung cancer. The pharmaceutical composition is prepared from the following active pharmaceutical ingredients in parts by weight: 15-18parts of radix
ginseng, 15-18 parts of radix scrophulariae, 15-18 parts of radix astragali, 15-18 parts of radix adenophorae, 15-18 parts of sichuan fritillary
bulb, 15-18 parts of
balloon flower, 15-18 parts of radix sophorae flavescentis, 15-18 parts of rhizoma atractylodis macrocephalae, 15-18 parts of heartleaf
houttuynia herb, 15-18 parts of herba rabdosiae rubescentis, 15-18 parts of herbascutellariae barbatae, 15-18 parts of spreading
hedyotis herb, 15-18 parts of rhizoma paridis chinensis, 15-18 parts of radix cynanchi paniculati, 15-18 parts of bittersweet
herb, 15-18 parts of blacknightshade herb, 15-18 parts of herba taraxaci, 15-18 parts of folium
cycas, 15-18 parts of Chinese honeylocust spine, 15-18 parts of
semen plantaginis, 15-18 parts of radix scutellariae, 15-18 partsof rhizoma pinelliae, 15-18 parts of
apricot kernel, 15-18 parts of rhizoma curcumae, 15-18 parts of radix notoginseng, 15-18 parts of Chinese
blister beetle, 15-18 parts of
scorpion, 15-18 parts ofmercurous
chloride and 15-18 parts of pearl
powder. The pharmaceutical composition disclosed by the invention can effectively relieve the symptoms of
lung cancer.